When Will The Weight-Loss Drug Tirzepatide Debut In India? Can It Be Misused?
16 Jul 2024 05:23 AM IST
Tirzepatide serves as the primary ingredient in Eli Lilly's pharmaceuticals, Mounjaro and Zepbound. Notably, Mounjaro targets diabetes management, whereas Zepbound is aimed at facilitating weight loss. According to medical experts, tirzepatide functions by mimicking two crucial hormones naturally produced in the body: GIP and GLP-1.